Jazz Pharmaceuticals Plc (JAZZ) Profitability Comparisons, Net Margin, Gross Margin, Tax rate, Cash Flow Margin Comparisons - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Jazz Pharmaceuticals Plc  (NASDAQ: JAZZ)

Jazz Pharmaceuticals Plc Profitability Comparisons

Select each Category to receive further Information



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

JAZZ Profitability Ratio

 Company Industry Sector S&P 500
Gross Profit Margin (Q2 MRQ) 0 % 70.91 % 65.43 % 46.05 %
Gross Margin (Q2 TTM) 73.74 % 71.73 % 66.39 % 46.3 %
Gross Profit Margin 5 Yr. Avg. - 66.05 % 64.67 % 47.07 %
EBITDA Margin (Q2 MRQ) 35.36 % 22.25 % 19.62 % 20.6 %
EBITDA Margin (Q2 TTM) 35.13 % 25.28 % 20.88 % 19.1 %
EBITDA Margin 5 Yr. Avg. 21.98 % 45.98 % 31.17 % 22.16 %
Operating Margin (Q2 MRQ) 20.54 % 17.27 % 16.57 % 16.03 %
Operating Margin (Q2 TTM) 19.49 % 20.33 % 17.92 % 16.33 %
Operating Margin 5 Yr. Avg. 5.27 % 15.55 % 14.41 % 17.09 %
Pre-Tax Profit Margin (Q2 MRQ) 17.46 % 13.66 % 10.93 % 13.94 %
Pre-Tax Profit Margin (Q2 TTM) 15.82 % 16.7 % 12.86 % 13.09 %
Pre-Tax Profit Margin 5 Yr. Avg. - 13.09 % 10.45 % 12.49 %
Net Margin (Q2 MRQ) 15.96 % 10.09 % 8.14 % 11.41 %
Net Margin (Q2 TTM) 20.45 % 13.13 % 9.99 % 10.75 %
Net Margin 5 Yr. Avg. - 6.22 % 6.23 % 9.95 %



Business Segment Profit Margin
 
United States
  Explore United States Segment  -
Europe
  Explore Europe Segment  -
All other
  Explore All other Segment  -
Xywav
  Explore Xywav Segment  -
Xyrem
  Explore Xyrem Segment  -
Zepzelca
  Explore Zepzelca Segment  -
Vyxeos
  Explore Vyxeos Segment  -
Ziihera
  Explore Ziihera Segment  -
Other
  Explore Other Segment  -
Sleep
  Explore Sleep Segment  -
Epilepsy
  Explore Epilepsy Segment  -
Oncology
  Explore Oncology Segment  -
Modeyso
  Explore Modeyso Segment  -
Product and Services, Product Sales Net of Deductions
  Explore Product and Services, Product Sales Net of Deductions Segment  -
Product and Services, Royalties and Contract Revenue
  Explore Product and Services, Royalties and Contract Revenue Segment  -
Epidiolex/Epidyolex
  Explore Epidiolex/Epidyolex Segment  -
Rylaze/Enrylaze
  Explore Rylaze/Enrylaze Segment  -
Defitelio/defibrotide
  Explore Defitelio/defibrotide Segment  -
High Sodium AG Oxybate Product Royalty Revenue
  Explore High Sodium AG Oxybate Product Royalty Revenue Segment  -
Other Countries
  Explore Other Countries Segment  -
 

Company's Cashflow Profitability & Other



Profitability Ratios Company Industry Sector S&P 500
Free Cash Flow Margin (Q2 MRQ) 32.91 % -0.01 % 0.21 % 1.39 %
Free Cash Flow Margin (Q2 TTM) 31.09 % 17.23 % 14.01 % 9.24 %
Free Cash Flow Margin 5 Yr. Avg. - 20.2 % 15.38 % 14.52 %
Net Cash Flow Margin (Q2 MRQ) 0 % 0.02 % -0.02 % 0.13 %
Net Cash Flow Margin (Q2 TTM) 14.22 % -0.78 % 0.08 % 1.81 %
Net Cash Flow Margin 5 Yr. Avg. - 4.28 % 3.13 % 5.85 %
Effective Tax Rate (Q2 MRQ) 8.58 % 25.98 % 25.41 % 18.83 %
Effective Tax Rate (Q2 TTM) -29.31 % 21.22 % 22.81 % 19.33 %
Effective Tax Rate 5 Yr. Avg. - 15.14 % 20.39 % 19.86 %
Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.